Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-30
2007-01-30
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S486000
Reexamination Certificate
active
11074288
ABSTRACT:
The present invention provides novel N-substituted fluorooxindoles having the general Formula Iwherein the wavy bondrepresents the racemate, the (R)-enantiomer or the (S)-enantiomer and m, n, p, q, A, B, D, Q, X, and Z are as defined below, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.
REFERENCES:
patent: 5602169 (1997-02-01), Hewawasam et al.
patent: 6930100 (2005-08-01), Gillman et al.
patent: WO 90/08128 (1990-07-01), None
Ahmed, F., et al., “Some Features of the Spasmogenic Actions of Acetylcholine and Histamine in Guinea-Pig Isolated Trachealis”,Br. J. Pharmacol., 83: 227-233 (1984).
Baró, I. and Escande, D., “A Ca2+-activated K+Current in Guinea-pig Atrial Myocytes”,Pflügers Archiv., 414 (Suppl. 1): S168 (1989).
Bungaard, et al., “A Novel Solution-Stable, Water-Soluble Prodrug Type for Drugs Containing a Hydroxyl or an NH-Acidic Group”,J. Med. Chem., 32(12): 2503-2507 (1989).
Cook, N.S., “The Pharmacology of Potassium Channels and Their Therapeutic Potential”,Trends in Pharmacol. Sciences, 9: 21-28 (Jan. 1988).
Gribkoff, et al., “Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels”,Nature Medicine, 7(4): 471-477 (2001).
Koh, D-S., et al., “Effect of the Flavoid Phloretin on Ca2+-activated K+Channels in Myelinated Nerve Fibres ofXenopus laevis”, Neuroscience Lett., 165: 167-170 (1994).
Quast, U. and Cook, N. S , “Moving Together: K+Channel Openers and ATP-sensitive K+Channels”,Trends in Pharmacol. Sciences, 10: 431-435 (Nov. 1989).
Singer, J. J. and Walsh, J.V., “Characterization of Calcium-activated Potassium Channels in Single Smooth Muscle Cells Using the Patch-clamp Technique”,Pflügers Archiv., 408: 98-111 (1987).
Trivedi, S., et al., “Calcium Dependent K-Channels in Guinea Pig and Human Urinary Bladder”,Biochemical and Biophysical Research Communications, 213( 2): 404-409 (Aug. 1995).
Varia, S.A., et al., Phenytoin Prodrugs III: Water-Soluble Prodrugs for Oral and/or Parenteral Use:,J. Pharm. Sci., 73(8): 1068-1073 (1984).
Ding Min
Hewawasam Piyasena
Lopez Omar D.
Starrett, Jr. John E.
Algieri Aldo A.
Barker Michael P.
Bristol--Myers Squibb Company
McKane Joseph K.
LandOfFree
N-substituted prodrugs of fluorooxindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted prodrugs of fluorooxindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted prodrugs of fluorooxindoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3800982